Literature DB >> 22486579

Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life.

J Tack1, A Becher, C Mulligan, D A Johnson.   

Abstract

BACKGROUND: About one-third of patients with gastro-oesophageal reflux disease (GERD) have frequent and/or severe reflux symptoms ('disruptive GERD'). The relative burden of disruptive GERD on health-related quality of life (HRQL) has not been systematically investigated. AIM: To assess the burden of disruptive vs. nondisruptive GERD on HRQL.
METHODS: Systematic searches were conducted in PubMed and Embase. To be included, studies had to have used validated questionnaires to assess HRQL.
RESULTS: Nineteen studies were included. Data on the comparative burden of frequent (ranging from daily to ≥weekly) and severe reflux symptoms were provided in eight and 13 studies respectively; six reported on the additional burden of nocturnal symptoms. Compared with individuals with nondisruptive GERD, those with disruptive GERD had 2.4-times and 1.5-times higher mean rates of absenteeism and presenteeism respectively (five studies), 1.5-times lower sleep quality scores (three studies), 1.1-times lower mean summary scores for physical and mental health (five studies) and 1.3-times lower mean scores for psychological and general well-being (four studies). Increasing symptom frequency and severity both increased the burden of disease to a similar extent. The presence of nocturnal symptoms in addition to daytime symptoms led to worsening of physical health, but their effect on mental health and work productivity was less clear.
CONCLUSIONS: Disruptive GERD is associated with a high burden of disease compared with occasional or mild reflux symptoms. Disease management needs to vary across the GERD spectrum and should be tailored to patients' requirements for optimal therapeutic outcomes.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22486579     DOI: 10.1111/j.1365-2036.2012.05086.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  44 in total

1.  Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.

Authors:  Ching-Sheng Hsu; Shu-Hui Wen; Jui-Sheng Hung; Tso-Tsai Liu; Chih-Hsun Yi; Wei-Yi Lei; Fabio Pace; Chien-Lin Chen
Journal:  Dig Dis Sci       Date:  2017-01-23       Impact factor: 3.199

Review 2.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

Review 3.  Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.

Authors:  Yu-Min Kung; Wen-Hung Hsu; Meng-Chieh Wu; Jiunn-Wei Wang; Chung-Jung Liu; Yu-Chung Su; Chao-Hung Kuo; Fu-Chen Kuo; Deng-Chyang Wu; Yao-Kuang Wang
Journal:  Dig Dis Sci       Date:  2017-11-06       Impact factor: 3.199

4.  Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.

Authors:  Yuta Yokoya; Ataru Igarashi; Akihito Uda; Hisato Deguchi; Toshihisa Takeuchi; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2019-08-08       Impact factor: 7.527

5.  Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.

Authors:  Maria do Rosário Dias de Oliveira Latorre; Aline Medeiros da Silva; Décio Chinzon; Jaime N Eisig; Telma R P Dias-Bastos
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Psychoemotional factors and their influence on the quality of life in patients with GERD.

Authors:  Charles Hill; Yvonne Versluijs; Elisa Furay; Deonna Reese-White; Cole Holan; Jeremiah Alexander; Stephanie Doggett; David Ring; F P Buckley
Journal:  Surg Endosc       Date:  2020-11-25       Impact factor: 4.584

7.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

Review 8.  Sorting out the Relationship between Gastroesophageal Reflux Disease and Sleep.

Authors:  Michael Kurin; Fahmi Shibli; Yoshitaka Kitayama; Yeseong Kim; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2021-08-02

Review 9.  Gastroesophageal reflux and rhinosinusitis.

Authors:  Elin-Johanne Katle; Jan G Hatlebakk; Sverre Steinsvåg
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

10.  Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.

Authors:  Milind Alai; Wen Jen Lin
Journal:  AAPS J       Date:  2014-02-12       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.